Russian President Vladimir Putin hinted at this advancement, stating that the country was nearing the completion of its ...

Russia’s Ministry of Health said it has developed its own mRNA vaccine against cancer but didn’t reveal the vaccine’s ...

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

Merck & Co Inc (NYSE:MRK) revealed that it would discontinue the clinical development programs for vibostolimab and ...

Shares of Merck & Co. Inc. MRK were unchanged Tuesday, on what proved to be an all-around dismal trading session for the ...

Vaccinations provide significant protection for the public against infectious diseases and substantially reduce health care ...

Netflix co-founder Reed Hastings and former New York City mayor Michael Bloomberg made the largest contributions in 2024, and ...

The Russian Ministry of Health claims it will begin distributing vaccinations against cancer as soon as early 2025.

Merck & Co. on Tuesday said the Food and Drug Administration has accepted its application seeking approval of its proposed clesrovimab vaccine aimed at protecting infants from respiratory syncytial ...

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...

Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline clear outs, and 2024 is ...